Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Reardon Andrew sold 5,000 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Reardon Andrew (CLO & Secretary) sold 5,000 Ligand Pharmaceuticals Incorporated shares at an average US$313.22 for US$1.57M under a trading plan, leaving 31,854 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$313.22 average (US$307.39 to US$323.14)
- Value
- US$1.57M
- Holding after
- 31,854 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CLO & Secretary
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Option exercise | 5,000 | US$52.27 | 36,854 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 283 | US$307.39 | 36,571 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 708 | US$308.43 | 35,863 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 522 | US$309.91 | 35,341 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 490 | US$310.61 | 34,851 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 520 | US$311.72 | 34,331 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 634 | US$312.85 | 33,697 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 403 | US$313.75 | 33,294 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 80 | US$314.58 | 33,214 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 280 | US$317.91 | 32,934 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 440 | US$318.73 | 32,494 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 320 | US$319.97 | 32,174 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 200 | US$321.44 | 31,974 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 120 | US$323.14 | 31,854 | Direct |
Source
Download original · View original at SEC
Related
- Ligand Pharmaceuticals Incorporated
- Reardon Andrew
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Reardon Andrew · Aug 4, 2026
- Form 4 · Reardon Andrew · Jul 6, 2026
- Form 4 · Reardon Andrew · Jun 2, 2026
- Form 4 · Kozarich John W · Nov 16, 2026
- Form 4 · Zimmermann Martine · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Aryeh Jason · Nov 12, 2026
- Schedule 13G/A · Invesco Ltd. · Nov 10, 2026